A portfolio sells on demonstrated relevance. ClaimHit screens each asset against the live market, ranks what it finds by how strong the evidence actually is, and gives you charts you can put in the data room.
Upload a batch and let each asset run through the same pipeline. Assets with live, evidenced targets separate themselves from the ones that do not.
Results are sorted by what could actually be verified — confirmed on a manufacturer's own page, or agreed by the models but unconfirmed. The distinction is stated, not blurred.
Element-by-element Hit Charts with the evidence behind every limitation — the artefact a buyer's counsel will actually read.
Beyond the obvious names: component distributors, regulatory records, software catalogues and marketplaces are searched by field, so mid-market practitioners surface too.
Candidates come from several models, live web and neural search, forward citations, and the authoritative registries for the field — but breadth only widens the net. Each one is still checked against real, citable evidence, and anything that cannot be evidenced is dropped rather than shown with a caveat. See every source →
Run one asset you have already sold, and compare what comes back to what you found by hand.
Apply for Beta Access →